Products from TargetMol

TargetMol

TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.

More information at: www.targetmol.com

Go to the catalogs of TargetMol

12292 from 12311 pages
No results were found for the filter!
IRAK4-IN-12
IRAK4-IN-12

Item number: TGM-T62989-100mg

Description: IRAK4-IN-12 (compound 37) is a potent inhibitor of IRAK4 with an IC50 of 0.015 µM and demonstrates cellular pIRAK4 potency with an IC50 of 0.5 µM. Target: Others
MW: 466.55 D
From 1,440.00€ *
Review
PI3K/AKT-IN-1
PI3K/AKT-IN-1

Item number: TGM-T62997-100mg

Description: PI3K/AKT-IN-1 is a potent, dual PI3K/AKT inhibitor that acts on PI3Kgamma (IC50: 6.99 µM), PI3Kdelta (IC50: 4.01 µM) and AKT (IC50: 3.36 µM). PI3K/AKT-IN-1 induces caspase 3-dependent apoptosis by inhibiting the PI3K/AKT pathway. caspase 3-dependent apoptosis and exhibited anticancer effects. Target:...
MW: 467.54 D
From 393.00€ *
Review
VEGFR-2-IN-15
VEGFR-2-IN-15

Item number: TGM-T63002-100mg

Description: VEGFR-2-IN-15 (Compound 14b) is a potent VEGFR-2 inhibitor that inhibits the growth of HepG2 cells in the Pre-G1 phase and induces apoptosis. Target: Others
MW: 467.92 D
From 1,440.00€ *
Review
DHU-Se1
DHU-Se1

Item number: TGM-T63006-100mg

Description: DHU-Se1 is a potent anti-inflammatory agent that stimulates the release of reactive selenium compounds from macrophages and reduces the expression of cellular inflammatory factors such as iNOS and TNF-alpha. Additionally, DHU-Se1 blocks the polarization of macrophages from M0 to M1, thereby alleviating...
MW: 468.47 D
From 1,440.00€ *
Review
SphK2-IN-2
SphK2-IN-2

Item number: TGM-T63017-100mg

Description: SphK2-IN-2 (21g) is a potent and selective SphK2 inhibitor with an IC50 of 0.23 µM. Target: Others
MW: 468.94 D
From 1,440.00€ *
Review
GKA50 quarterhydrate
GKA50 quarterhydrate

Item number: TGM-T63019-100mg

Description: GKA50 quarterhydrate is a potent glucokinase activator with an EC50 value of 33 nM. This glucose-like activator of beta-cell metabolism in rodent and human pancreatic islets is a Ca2+-dependent regulator of insulin secretion. It stimulates insulin secretion in mouse islets and significantly reduces...
MW: 469.01 D
From 1,251.00€ *
Review
PTP1B-IN-17
PTP1B-IN-17

Item number: TGM-T63021-100mg

Description: PTP1B-IN-17 (Compound 45) is a selective benzimidazole derivative with potential as a protein tyrosine phosphatase 1B (PTP1B) inhibitor (Ki: 30.2 µM). PTP1B-IN-17 can be used in the study of type 2 diabetes. Target: Others
MW: 469.51 D
From 1,440.00€ *
Review
PTP1B-IN-18
PTP1B-IN-18

Item number: TGM-T63022-100mg

Description: PTP1B-IN-18 is an orally active, fully mixed protein tyrosine phosphatase 1B (PTP1B) inhibitor with a Ki of 35.2 µM, and it can be used for the study of type 2 diabetes. Target: Others
MW: 469.51 D
From 1,440.00€ *
Review
PTP1B-IN-19
PTP1B-IN-19

Item number: TGM-T63023-100mg

Description: PTP1B-IN-19 (Compound 43) is a promising selective benzimidazole derivative that acts as a protein tyrosine phosphatase 1B (PTP1B) inhibitor with a Ki of 23.3 µM. This compound, along with PTP1B-IN-17, can be utilized in the study of type 2 diabetes. Target: Others
MW: 469.51 D
From 1,440.00€ *
Review
JAK-IN-19
JAK-IN-19

Item number: TGM-T63026-100mg

Description: JAK-IN-19 is a potent JAK inhibitor with pIC50 values of 7.2 for PBMC (IFNgamma) and 7.7 for HLF (Eotaxin). The compound also exhibits pIC50 values of 7.0 for VEGFR2 and 5.8 for Aurora B. Target: Others
MW: 469.59 D
From 1,440.00€ *
Review
Antibacterial agent 66
Antibacterial agent 66

Item number: TGM-T63027-100mg

Description: Antibacterial agent 66 (Compound 6q) is a trifluoromethylpyridine 1,3,4-oxadiazole derivative active against Xanthomonas oryzae pv. oryzae (Xoo) (EC50: 7.2 µg/mL). Target: Others
MW: 469.79 D
From 1,440.00€ *
Review
KRAS G12D inhibitor 12
KRAS G12D inhibitor 12

Item number: TGM-T63028-100mg

Description: KRAS G12D inhibitor 12 is an effective inhibitor of KRAS G12D. The Ras protein family is an important intracellular signaling molecule, which plays an important role in growth and development. KRAS G12D inhibitor 12 has the potential to perform KRAS G12D-mediated cancer studies. Target: Others
MW: 469.9 D
From 1,440.00€ *
Review
12292 from 12311 pages